Overview

Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer

Status:
Withdrawn

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Toremifene Citrate is effective in reducing the risk of bone fractures in men with prostate cancer who are on Androgen Deprivation Therapy.

Phase:

Phase 3

Details

Lead Sponsor:

GTx

Collaborator:

Ipsen

Treatments:

Androgens
Citric Acid
Toremifene